Browse the corpus

Walk the evidence base by book and chapter — the raw source passages that ground Ask, Differential, and the rest.

• Allergen immunotherapy for allergic asthma: A systematic review and meta-analysis1 passage
• Allergic Rhinitis and Its Impact on Asthma (ARIA)-EAACI Guidelines-2024-2025 Revision: Part I-Guidelines on Intranasal Treatments1 passage
• Allergic Rhinitis and Its Impact on Asthma (ARIA)-EAACI Guidelines-2024-2025 Revision: Part II-Guidelines on Oral and Ocular Treatments1 passage
• Comparative Efficacy of Seven Biologics for Chronic Rhinosinusitis With Nasal Polyps: A Network Meta-Analysis1 passage
• Cost-Effectiveness of Allergen Immunotherapy for Allergic Rhinitis: A Systematic Review1 passage
• Diagnosing, managing and preventing anaphylaxis: Systematic review1 passage
• Diagnosis and management of NSAID-Exacerbated Respiratory Disease (N-ERD)-a EAACI position paper1 passage
• EAACI Guidelines on Allergen Immunotherapy: Allergic rhinoconjunctivitis1 passage
• EAACI Guidelines on allergen immunotherapy: IgE-mediated food allergy1 passage
• EAACI guidelines on allergen immunotherapy: Hymenoptera venom allergy1 passage
• EAACI guidelines on the management of IgE-mediated food allergy1 passage
• EAACI guidelines: Anaphylaxis (2021 update)1 passage
• EAACI position paper on how to classify cutaneous manifestations of drug hypersensitivity1 passage
• Early initiation of short-term emollient use for the prevention of atopic dermatitis in high-risk infants-The STOP-AD randomised controlled trial1 passage
• Efficacy and Safety of Biologics for Chronic Rhinosinusitis With Nasal Polyps: A Meta-Analysis of Real-World Evidence1 passage
• Efficacy and safety of intranasal medications for allergic rhinitis: Network meta-analysis1 passage
• Efficacy and safety of treatment with biologicals (benralizumab, dupilumab, mepolizumab, omalizumab and reslizumab) for severe eosinophilic asthma. A systematic review for the EAACI Guidelines - recommendations on the use of biologicals in severe asthma1 passage
• Emollients for prevention of atopic dermatitis: 5-year findings from the BEEP randomized trial1 passage
• Frequency of food allergy in Europe: An updated systematic review and meta-analysis1 passage
• Head-To-Head Comparison of Biologic Efficacy in Asthma: What Have We Learned?1 passage
• Is exposure to pollen a risk factor for moderate and severe asthma exacerbations?1 passage
• Patients' values and preferences for health states in allergic rhinitis-An artificial intelligence supported systematic review1 passage
• Patterns and Clinical Efficacy of Biologics Switching in Patients With Severe Asthma: A Systematic Review and Meta-Analysis23 passages
• Phase 2a randomized clinical trial of dupilumab (anti-IL-4Rα) for alopecia areata patients1 passage
• Predictors of Response to Biologics for Severe Asthma: A Systematic Review and Meta-Analysis25 passages
• Risk factors for severe reactions in food allergy: Rapid evidence review with meta-analysis1 passage
• The impact of outdoor pollution and extreme temperatures on asthma-related outcomes: A systematic review for the EAACI guidelines on environmental science for allergic diseases and asthma1 passage
• The international EAACI/GA²LEN/EuroGuiDerm/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria1 passage